Welcome to our dedicated page for National Vision SEC filings (Ticker: EYE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for National Vision Holdings, Inc. (NASDAQ: EYE), a Delaware-incorporated optical retail company. As a Nasdaq-listed issuer, National Vision files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents. These filings offer detailed information on the company’s financial condition, risk factors, governance, and material events.
National Vision’s Form 8-K filings have covered topics such as quarterly financial results, amendments to material agreements, annual meeting voting outcomes, and changes in directors and executive officers. For example, recent 8-Ks have reported results of operations and financial condition, board and leadership changes, and an amendment to a letter agreement with a key business partner. These documents help investors track developments that the company deems material.
In its SEC reports, National Vision discusses its optical retail operations, including its store footprint, brand portfolio, and operating segments, as well as non-GAAP financial measures like Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, and Adjusted Comparable Store Sales Growth. The filings describe how these measures are defined and reconciled to GAAP, and outline the risks and uncertainties that could affect future performance, such as competition, macroeconomic conditions, technology investments, regulatory compliance, and vendor relationships.
On Stock Titan, National Vision’s filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the key points in lengthy documents such as 10-K and 10-Q reports or detailed 8-K disclosures. Users can also review information related to governance matters, executive and director changes, and other regulatory disclosures associated with the EYE ticker.
Event: On August 1, 2025 the Board of National Vision Holdings, Inc. (NASDAQ: EYE) increased its size to eleven directors and appointed Alex Wilkes as a director effective August 1, 2025.
Context: The appointment was made in accordance with the Company's CEO succession plan previously disclosed in the Current Report on Form 8-K filed April 29, 2025. Under that plan, Reade Fahs will become Executive Chairman and Mr. Wilkes will succeed Mr. Fahs as Chief Executive Officer.
- Filing type: Form 8-K dated August 4, 2025 (earliest event reported August 1, 2025).
- Exhibit included: Exhibit 104 (Cover Page Interactive Data File - Inline XBRL).
On June 18, 2025, National Vision Holdings, Inc. (Nasdaq: EYE) held its 2025 Annual Meeting of Stockholders, with the Form 8-K filed on June 23, 2025 summarizing the certified results.
Key outcomes
- Election of Directors (Proposal 1): All eight nominees were re-elected for terms expiring at the 2026 meeting. Support levels exceeded 98% of votes cast, with Michael J. Nicholson receiving the highest approval (≈99.9% in favor).
- Say-on-Pay (Proposal 2): The advisory vote on executive compensation passed with 65.7 million votes for (≈97%) versus 2.0 million against.
- Auditor Ratification (Proposal 3): Deloitte & Touche LLP was ratified as independent registered public accounting firm for fiscal 2025 with 71.6 million votes for (≈98.7%).
No other substantive matters, financial results, or strategic transactions were reported. The filing is primarily a routine governance disclosure confirming shareholder support for the Board, executive pay program, and auditor.
National Vision Holdings, Inc. (EYE) – Form 4 filing dated 06/23/2025
Director Susan C. O’Farrell reported the award of 9,674 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one share of common stock and will vest 100 % on the first anniversary of the grant date. The grant was recorded at $0 acquisition cost, indicating it is an equity-based compensation award rather than an open-market purchase.
Following the grant, O’Farrell’s total beneficial ownership increased to 22,333 shares, all held directly. No derivative securities or sales were disclosed. The transaction modestly increases insider alignment with shareholders, while the share count involved is immaterial relative to EYE’s outstanding shares and therefore has no meaningful dilutive impact.
National Vision Holdings, Inc. (EYE) filed a Form 4 disclosing that director Michael J. Nicholson received 7,392 restricted stock units (RSUs) on 06/18/2025. Each RSU converts into one common share upon vesting, which occurs in full on the first anniversary of the grant date. The award was issued at $0 cost to the director and did not involve an open-market transaction. Following the grant, Nicholson’s total beneficial ownership increased to 10,719 common shares, all held directly. No derivative securities or simultaneous dispositions were reported.
This is a routine equity compensation grant aimed at aligning board member incentives with shareholder interests. The transaction represents approximately 0.01% of EYE’s ~80 million shares outstanding, so market impact is expected to be minimal.
National Vision Holdings, Inc. (EYE) – Form 4 filing overview:
Director James M. McGrann reported the grant of 7,392 restricted stock units (RSUs) on 18 June 2025. Each RSU represents the right to receive one share of common stock and will vest in full on the first anniversary of the grant date. Following the award, McGrann’s direct beneficial ownership rises to 10,719 shares. The transaction was coded “A” (acquired) and carries a price of $0, indicating it is part of routine director compensation rather than an open-market purchase.
No derivative securities were reported, and there are no indications of sales or dispositions. The disclosure is single-person, routine, and compensation-related, with limited immediate market impact.
National Vision Holdings (EYE) – Form 4 filing overview: On 06/18/2025, independent director Naomi Kelman received an equity award of 7,392 restricted stock units (RSUs), each convertible into one share of common stock. The RSUs were granted at $0 cost and will vest in full on the first anniversary of the grant date, subject to continued service. Following the award, Kelman’s total direct beneficial ownership increased to 41,041 shares.
No shares were sold and no cash was exchanged, indicating the transaction is a routine annual equity grant designed to align director incentives with shareholder interests. No derivative positions or additional transactions were reported.